1. Screening Libraries
  2. Protein Tyrosine Kinase Compound Library

Protein Tyrosine Kinase Compound Library

(291 compounds) Cat. No.: HY-L016
Library Contents: XLSX PDF

A unique collection of 291 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

sales@MedChemExpress.com

Top Publications Citing Use of Products

Customer Validation

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 291 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

•   Targets such as VEGFR, ALK, Btk, Bcr-Abl, c-Met/HGFR, EGFR, FGFR, Insulin Receptor, JAK, PDGFR, etc.

•   A useful tool for the research for PTK-related diseases, such as cancer.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some protein kinase inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active and cell permeable.

•   Rich documentation with structure, IC50 and summary.

•   NMR and HPLC to ensure the high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 291 protein kinase inhibitors supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Contents of Protein Tyrosine Kinase Compound Library

Plate layout: HY-L016-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty NVP-BAW2881 AEE788 Nilotinib Nilotinib (monohydrochloride monohydrate) Dasatinib Dasatinib (hydrochloride) Linsitinib NVP-TAE 684 BMS-754807 Tandutinib Empty
b Empty OSI-930 Cediranib Amuvatinib Pazopanib Masitinib CUDC-101 Motesanib Motesanib (Diphosphate) Saracatinib AG1024 Empty
c Empty Sunitinib Vandetanib Afatinib Afatinib (dimaleate) BMS-536924 PD173074 BIBX 1382 CL-387785 Toceranib Toceranib (phosphate) Empty
d Empty Regorafenib Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib KW-2449 KX2-391 (dihydrochloride) Canertinib (dihydrochloride) PP121 SU5416 Empty
e Empty SU 5402 Ki20227 PF-562271 (besylate) PF-573228 BMS-794833 SU14813 SU14813 (maleate) TSU-68 GSK1904529A Telatinib Empty
f Empty EG00229 GW2580 GNF-7 Tivozanib Lenvatinib ENMD-2076 (Tartrate) ENMD-2076 MGCD-265 analog PCI-32765 GNF-2 Empty
g Empty BIBF 1120 (esylate) PHA-665752 R406 (free base) CGI-1746 AG-490 Erlotinib (Hydrochloride) Pazopanib (Hydrochloride) BMS-599626 (Hydrochloride) PD153035 (Hydrochloride) SU11274 Empty
h Empty PF-04217903 PF-04217903 (methanesulfonate) Vatalanib SGX-523 WZ4002 AMG-208 Ki8751 Cabozantinib (S-malate) Ponatinib CP-673451 Empty

Plate layout: HY-L016-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty KRN-633 R406 DPH LDN193189 LDN193189 (Hydrochloride) Lck Inhibitor BMS 777607 PF-06463922 DMH-1 ML347 Empty
b Empty AZ191 K02288 Defactinib WH-4-023 KRCA-0008 UNC2025 UNC2025 (hydrochloride) Y15 LDC1267 ANA-12 Empty
c Empty Entrectinib BLZ945 BLU9931 Brigatinib TP-0903 SGI-7079 Quizartinib CH5424802 CH5424802 (Hydrochloride) Cabozantinib Empty
d Empty GSK1838705A DCC-2036 R788 (disodium hexahydrate) Cediranib (maleate) Sapitinib E-7050 NVP-TAE 226 Crenolanib OSI-420 NVP-BHG712 Empty
e Empty Dacomitinib LY2874455 Regorafenib (Hydrochloride) NVP-BGJ398 ASP3026 AZD4547 Apatinib INCB28060 ALK-IN-1 GNF-5837 Empty
f Empty Mubritinib Piceatannol Nocodazole SB-505124 AG-1478 AZM475271 PQ401 R1530 ZM 306416 PP1 Empty
g Empty PP2 PLX647 WHI-P154 CNX-2006 Flumatinib Flumatinib (mesylate) TCS 359 PND-1186 1-Naphthyl PP1 1-Naphthyl PP1 (hydrochloride) Empty
h Empty 1-NM-PP1 CNX-774 SKLB1002 DDR1-IN-1 PD153035 Genistein CP-724714 EMD-1214063 BAY 61-3606 (dihydrochloride) AST 487 Empty

Plate layout: HY-L016-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Icotinib (Hydrochloride) SB1317 TAK-285 c-Kit-IN-1 AIM-100 PRT062607 (Hydrochloride) ALK inhibitor 2 NVP-BVU972 SAR131675 Imatinib Empty
b Empty ZM323881 (hydrochloride) AXL1717 Tyrphostin A9 SSR128129E AZD-3463 AG 18 LDK378 LDK378 (dihydrochloride) GZD824 CO-1686 Empty
c Empty CO-1686 (hydrobromide) Poziotinib GNF-5 XL228 A 419259 (trihydrochloride) ONO-4059 AZD-9291 AZD-9291 (mesylate) UNC2881 ID-8 Empty
d Empty AMG 925 LDN-212854 GS-9973 H-89 (dihydrochloride) Cerdulatinib JI-101 LDN-214117 Pexidartinib Sitravatinib Acalabrutinib Empty
e Empty LFM-A13 AVL-292 CEP-28122 (mesylate salt) AZD2932 SKLB610 GW 441756 FIIN-2 PD158780 CPDA AMG-337 Empty
f Empty c-Met inhibitor 2 AZD3759 ONO-4059 (analog) MCB-613 Olmutinib Fruquintinib CH5183284 Pelitinib Neratinib JNJ-38877605 Empty
g Empty Tivantinib Linifanib Bafetinib Crizotinib Crizotinib (hydrochloride) Gefitinib Gefitinib (hydrochloride) Erlotinib Lapatinib Lapatinib (ditosylate) Empty
h Empty BIBF 1120 Dovitinib Imatinib (Mesylate) MNS AZD-9291 (dimesylate) SU6656 AZ-5104 Scutellarein Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Protein Tyrosine Kinase Compound Library
Cat. No.:
HY-L016
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.